Form 4: Inari Medical Director William Hoffman Reports Stock Sales

Director William Hoffman of Inari Medical, Inc. reports selling shares of common stock in multiple transactions between August 16 and August 19, 2024, under a pre-arranged trading plan.

Summary

• William Hoffman, a director at Inari Medical, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On August 16, 2024, Hoffman sold 24,553 shares of common stock at a weighted average price of $48.72 and another 15,447 shares at a weighted average price of $49.17.
• On August 19, 2024, Hoffman sold 20,000 shares of common stock at a weighted average price of $50.3.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
• Following these transactions, Hoffman beneficially owns 683,296 shares of Inari Medical, Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports routine stock sales by a company director under a pre-arranged trading plan. There's no indication of unusual or concerning activity.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may interpret the stock sales as a lack of confidence by the director, although the pre-arranged trading plan mitigates this concern.

Key Dates